The U.S. Food & Drug Administration (FDA) has granted approval for a novel and less invasive belimumab (Benlysta®) treatment for children with systemic lupus erythematosus (SLE) ages five years and ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a 200 mg Benlysta autoinjector for children aged 5 years and ...

Please provide your email address to receive an email when new articles are posted on . Reversing Autoimmunity through Cell Therapy (REACT-01) is expected to launch this summer. The trial will be led ...

Seattle Children’s is the first FDA-authorized site to deliver an experimental CAR T-cell therapy to children with lupus, the system said March 11. About 20% of lupus patients have disease onset ...

With this approval, pediatric patients aged five years and older with active lupus nephritis will have a first-of-its-kind treatment option for at-home administration. PHILADELPHIA--(BUSINESS WIRE)-- ...

Women with lupus are twice as likely to have a child with autism compared to mothers without the autoimmune disease, new, preliminary research finds. However, the overall risk is still low and the ...

A multi-institutional team of scientists, led by researchers at Weill Cornell Medicine’s Gale and Ira Drukier Institute for Children's Health, have received a five-year $8.297 grant to continue ...

SAN DIEGO — Children born to women with lupus are at twice the risk for autism spectrum disorders as children born to women without a chronic inflammatory disease, according to a new study. "Mothers ...

The US Food and Drug Administration (FDA) has approved the launch of the first clinical trial for chimeric antigen receptor (CAR) T-cell therapy in children with systemic lupus erythematosus. The ...